balance equationreview2020-12-31
Difference 89209400 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$319.02M
Fiscal year ended 2025-12-31Net income
-$288.62M
Fiscal year ended 2025-12-31Total assets
$2.35B
Fiscal year ended 2025-12-31Core Scientific, Inc./tx (CORZ) reported revenue of $319.02M and net income of -$288.62M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Core Scientific, Inc./tx’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M | $60.32M |
| Cost of revenue | $281.12M | $389.60M | $378.94M | $631.91M | $305.62M | $50.93M |
| Gross profit | $37.90M | $121.07M | $123.46M | $8.40M | $238.86M | $9.39M |
| Operating income | -$245.59M | -$142.06M | $8.96M | -$2.11B | $131.49M | -$6.33M |
| Net income | -$288.62M | -$1.44B | -$246.49M | -$2.15B | $47.31M | -$12.21M |
| Research & development | Unavailable | $11.83M | $7.18M | $26.96M | $7.67M | $5.27M |
| Weighted-average diluted shares | shares 318.07M | shares 255.83M | shares 379.86M | shares 340.65M | shares 233.30M | shares 157.60M |
| Pretax income | -$288.03M | -$1.44B | -$245.80M | -$2.16B | $63.08M | -$12.21M |
| Income tax expense | $583.00K | $859.00K | $683.00K | -$17.09M | $15.76M | $0 |
| Diluted EPS | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 | $-0.14 |
| Selling, general & administrative | $159.22M | $113.69M | $108.11M | $226.01M | $64.55M | $16.32M |
| General & administrative | Unavailable | $110.45M | $93.91M | $213.28M | $60.49M | $14.55M |
| Selling & marketing | Unavailable | $9.97M | $7.02M | $12.73M | $4.06M | $1.77M |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $311.38M | $836.20M | $50.41M | $15.88M | $117.87M | Unavailable |
| Total assets | $2.35B | $1.48B | $712.16M | $807.69M | $2.44B | $15.00K |
| Current assets | $895.54M | $903.96M | $97.02M | $85.10M | $756.56M | Unavailable |
| Total liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.05B | $400 |
| Current liabilities | $781.40M | $134.56M | $488.42M | $186.79M | $320.29M | $400 |
| Total equity incl. NCI | -$962.74M | -$943.05M | -$596.94M | -$409.35M | $1.34B | $89.22M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | $0 | $44.48M | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | $1.02M | $1.00M | $234.00K | $1.38M | Unavailable |
| Goodwill | Unavailable | Unavailable | $0 | $0 | $1.06B | Unavailable |
| Long-term debt | $1.06B | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $126.11M | $19.26M | $154.75M | $53.64M | $11.62M | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Operating cash flow | $278.25M | $42.90M | $65.11M | $205.19M | -$56.74M | -$23.76M |
| Capital expenditures | $729.00M | $94.96M | $16.16M | $383.98M | $0 | $0 |
| Investing cash flow | -$740.75M | -$95.19M | -$3.00M | -$590.78M | -$423.84M | -$15.14M |
| Financing cash flow | -$63.10M | $819.57M | -$44.65M | $306.15M | $603.53M | $40.72M |
| Net change in cash | -$525.60M | $767.27M | $17.47M | -$79.44M | $122.96M | $1.81M |
| Stock-based compensation | $98.24M | $51.92M | $58.89M | $182.89M | $38.94M | $3.04M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | $0 | $0 | $31.65M | Unavailable | Unavailable |
| Depreciation & amortization | $68.91M | $113.20M | $96.00M | $225.26M | $33.36M | $9.40M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Free cash flow | -$450.75M | -$52.06M | $48.95M | -$178.79M | -$56.74M | -$23.76M |
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% |
| Operating margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% | -10.5% |
| FCF margin | -141.3% | -10.2% | 9.7% | -27.9% | -10.4% | -39.4% |
| SBC / revenue | 30.8% | 10.2% | 11.7% | 28.6% | 7.2% | 5.0% |
| Current ratio | 1.15x | 6.72x | 0.20x | 0.46x | 2.36x | Unavailable |
| Revenue YoY growth | -37.5% | 1.6% | -21.5% | 17.6% | 802.7% | Unavailable |
| Net margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | 4.2% | 1.4% | 8.7% |
| CapEx / revenue | 228.5% | 18.6% | 3.2% | 60.0% | 0.0% | 0.0% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | 25.0% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CORZ in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-28View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K/A · Filed 2026-03-02View SEC filing
10-Q/A · Filed 2026-03-02View SEC filing
10-Q/A · Filed 2026-03-02View SEC filing
10-Q/A · Filed 2026-03-02View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.